578 related articles for article (PubMed ID: 25087232)
1. CCR4 and its ligands: from bench to bedside.
Yoshie O; Matsushima K
Int Immunol; 2015 Jan; 27(1):11-20. PubMed ID: 25087232
[TBL] [Abstract][Full Text] [Related]
2. Production of thymus and activation-regulated chemokine and macrophage-derived chemokine by CCR4+ adult T-cell leukemia cells.
Shimauchi T; Imai S; Hino R; Tokura Y
Clin Cancer Res; 2005 Mar; 11(6):2427-35. PubMed ID: 15788694
[TBL] [Abstract][Full Text] [Related]
3. Mogamulizumab and the treatment of CCR4-positive T-cell lymphomas.
Remer M; Al-Shamkhani A; Glennie M; Johnson P
Immunotherapy; 2014; 6(11):1187-206. PubMed ID: 25496334
[TBL] [Abstract][Full Text] [Related]
4. Increased CCR4 expression in cutaneous T cell lymphoma.
Ferenczi K; Fuhlbrigge RC; Pinkus J; Pinkus GS; Kupper TS
J Invest Dermatol; 2002 Dec; 119(6):1405-10. PubMed ID: 12485447
[TBL] [Abstract][Full Text] [Related]
5. Evidence that phospholipase-C-dependent, calcium-independent mechanisms are required for directional migration of T-lymphocytes in response to the CCR4 ligands CCL17 and CCL22.
Cronshaw DG; Kouroumalis A; Parry R; Webb A; Brown Z; Ward SG
J Leukoc Biol; 2006 Jun; 79(6):1369-80. PubMed ID: 16614259
[TBL] [Abstract][Full Text] [Related]
6. Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells.
Mariani M; Lang R; Binda E; Panina-Bordignon P; D'Ambrosio D
Eur J Immunol; 2004 Jan; 34(1):231-40. PubMed ID: 14971049
[TBL] [Abstract][Full Text] [Related]
7. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine.
Imai T; Nagira M; Takagi S; Kakizaki M; Nishimura M; Wang J; Gray PW; Matsushima K; Yoshie O
Int Immunol; 1999 Jan; 11(1):81-8. PubMed ID: 10050676
[TBL] [Abstract][Full Text] [Related]
8. Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rgamma(null) mouse model.
Ito A; Ishida T; Yano H; Inagaki A; Suzuki S; Sato F; Takino H; Mori F; Ri M; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R
Cancer Immunol Immunother; 2009 Aug; 58(8):1195-206. PubMed ID: 19048251
[TBL] [Abstract][Full Text] [Related]
9. CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma.
Kumai T; Nagato T; Kobayashi H; Komabayashi Y; Ueda S; Kishibe K; Ohkuri T; Takahara M; Celis E; Harabuchi Y
Cancer Immunol Immunother; 2015 Jun; 64(6):697-705. PubMed ID: 25754123
[TBL] [Abstract][Full Text] [Related]
10. Reduction of regulatory T cells by Mogamulizumab, a defucosylated anti-CC chemokine receptor 4 antibody, in patients with aggressive/refractory mycosis fungoides and Sézary syndrome.
Ni X; Jorgensen JL; Goswami M; Challagundla P; Decker WK; Kim YH; Duvic MA
Clin Cancer Res; 2015 Jan; 21(2):274-85. PubMed ID: 25376389
[TBL] [Abstract][Full Text] [Related]
11. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells.
Iellem A; Mariani M; Lang R; Recalde H; Panina-Bordignon P; Sinigaglia F; D'Ambrosio D
J Exp Med; 2001 Sep; 194(6):847-53. PubMed ID: 11560999
[TBL] [Abstract][Full Text] [Related]
12. Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-cc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma.
Ogura M; Ishida T; Hatake K; Taniwaki M; Ando K; Tobinai K; Fujimoto K; Yamamoto K; Miyamoto T; Uike N; Tanimoto M; Tsukasaki K; Ishizawa K; Suzumiya J; Inagaki H; Tamura K; Akinaga S; Tomonaga M; Ueda R
J Clin Oncol; 2014 Apr; 32(11):1157-63. PubMed ID: 24616310
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of Th2 chemokine receptors on T cells from atopic and nonatopic asthmatics in response to Der p 1-pulsed dendritic cells.
Maneechotesuwan K; Wongkajornsilp A; Huabprasert S; Kasetsinsombat K; Suthumansami T
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S62-70. PubMed ID: 20364559
[TBL] [Abstract][Full Text] [Related]
14. Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC-derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammation.
Perros F; Hoogsteden HC; Coyle AJ; Lambrecht BN; Hammad H
Allergy; 2009 Jul; 64(7):995-1002. PubMed ID: 19630858
[TBL] [Abstract][Full Text] [Related]
15. Expression of chemokine receptor CCR4 and its ligands (CCL17 and CCL22) in murine contact hypersensitivity.
Kusumoto M; Xu B; Shi M; Matsuyama T; Aoyama K; Takeuchi T
J Interferon Cytokine Res; 2007 Nov; 27(11):901-10. PubMed ID: 18052724
[TBL] [Abstract][Full Text] [Related]
16. Serum CCL22 levels decreased in parallel with disease activity in CCR4-positive mycosis fungoides treated with mogamulizumab.
Ohuchi K; Fujimura T; Lyu C; Amagai R; Muto Y; Aiba S
Dermatol Ther; 2020 Nov; 33(6):e14099. PubMed ID: 32725764
[TBL] [Abstract][Full Text] [Related]
17. Effect of anti-CCR4 monoclonal antibody (mogamulizumab) on adult T-cell leukemia-lymphoma: cutaneous adverse reactions may predict the prognosis.
Yonekura K; Kanzaki T; Gunshin K; Kawakami N; Takatsuka Y; Nakano N; Tokunaga M; Kubota A; Takeuchi S; Kanekura T; Utsunomiya A
J Dermatol; 2014 Mar; 41(3):239-44. PubMed ID: 24628073
[TBL] [Abstract][Full Text] [Related]
18. Role of the chemokine receptor CCR4 and its ligand thymus- and activation-regulated chemokine/CCL17 for lymphocyte recruitment in cutaneous lupus erythematosus.
Wenzel J; Henze S; Wörenkämper E; Basner-Tschakarjan E; Sokolowska-Wojdylo M; Steitz J; Bieber T; Tüting T
J Invest Dermatol; 2005 Jun; 124(6):1241-8. PubMed ID: 15955100
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome.
Ishida T; Utsunomiya A; Iida S; Inagaki H; Takatsuka Y; Kusumoto S; Takeuchi G; Shimizu S; Ito M; Komatsu H; Wakita A; Eimoto T; Matsushima K; Ueda R
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3625-34. PubMed ID: 14506150
[TBL] [Abstract][Full Text] [Related]
20. Targeting CLA/E-selectin interactions prevents CCR4-mediated recruitment of human Th2 memory cells to human skin in vivo.
Biedermann T; Schwärzler C; Lametschwandtner G; Thoma G; Carballido-Perrig N; Kund J; de Vries JE; Rot A; Carballido JM
Eur J Immunol; 2002 Nov; 32(11):3171-80. PubMed ID: 12555662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
